What is the comparison between Terbinafine (antifungal) cream and Ciclopirox (antifungal) olamine cream?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Terbinafine cream is generally preferred over ciclopirox olamine cream for dermatophyte infections due to its fungicidal action and higher efficacy rates, as supported by studies such as 1 and 2. When considering the treatment of fungal infections, it's essential to choose the most effective medication based on the type of infection. Terbinafine and ciclopirox olamine are two antifungal creams with different properties and applications.

  • Terbinafine (typically 1% cream applied once or twice daily for 1-2 weeks) is specifically effective against dermatophytes, making it the preferred choice for infections like athlete's foot, ringworm, and jock itch.
  • Ciclopirox olamine (typically 0.77% cream applied twice daily for 2-4 weeks) has a broader spectrum of activity, including effectiveness against yeasts like Candida or Malassezia, making it more suitable for mixed infections. The mechanism of action also differs between the two: terbinafine works by inhibiting squalene epoxidase, disrupting fungal cell membrane synthesis, while ciclopirox interferes with multiple cellular processes including iron-dependent enzymes. Side effects for both medications are generally mild and include local irritation, burning, or redness, as noted in studies such as 3 and 4. Given the information from the most recent and highest quality studies, such as 1 and 2, the choice between terbinafine and ciclopirox olamine should be based on the specific fungal infection being treated, with terbinafine being more targeted for dermatophytes and ciclopirox offering broader coverage for mixed infections.

References

Research

Update on antifungal therapy with terbinafine.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2010

Research

Update on terbinafine with a focus on dermatophytoses.

Clinical, cosmetic and investigational dermatology, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.